Cefazolin 2 GM Injection

DRUG4 trials

Sponsors

B. Braun Medical Inc., Abdul El-Rabbany, Helwan University

Conditions

InfectionsOrthognathic Surgical Site InfectionSurgical Site Infection (SSI)

Phase 1

Pediatric Cefazolin PK Study

CompletedNCT01904357

B. Braun Medical Inc.Infections

Start: 2013-03-31End: 2013-09-30Updated: 2017-07-21

Phase 4

Antibiotics for Prevention of Infection Following Orthognathic Surgery

RecruitingNCT05852158

Abdul El-RabbanyOrthognathic Surgical Site Infection

Start: 2024-01-09End: 2027-07-01Target: 400Updated: 2026-03-19

Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During Orthopedic Surgeries in Egyptian Patients.

Not yet recruitingNCT07655596

Helwan UniversitySurgical Site Infection (SSI)

Start: 2026-07-01End: 2026-12-31Target: 100Updated: 2026-06-24

Continuous Infusion Versus Intermittent IV Bolus of Cefazolin: Prevention of Surgical Site Infection During CABG Surgeries in Egyptian Patients.

Not yet recruitingNCT07658378

Helwan UniversitySurgical Site Infection (SSI)

Start: 2026-07-01End: 2026-12-31Target: 100Updated: 2026-06-24

Related Papers

Determination of Appropriate Weight-Based Cutoffs for Empiric Cefazolin Dosing Using Data from a Phase 1 Pharmacokinetics and Safety Study of Cefazolin Administered for Surgical Prophylaxis in Pediatric Patients Aged 10 to 12 Years

Antimicrobial Agents and Chemotherapy2015-05-0510 citations